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Stress and depression The effect of  chronic negative conditions seems to amplify the link between acute 
life events and depressive symptoms.  
 
Disturbances in the sympathetic nervous system (SNS)  
is associated with depression neuroendocrine  
abnormalities. SNS hyperactivity and increased levels of   
plasma cathecolamines, primarily norepinephrine, are observed  
in most patients with MDD. These elevated levels of   
Norepinephrine enhanced the previous statements physiological  
effects of  stress. 
 
The hypothalamic pituitary adrenal axis (HPA) 
is a regulatory system, which integrates  
neural and endocrine functions.  
Under physical and physiological  
stressors: 
 
1.  Amygdala is activated, neuronal 
projection to paraventricular nucleus (PVN) 
2.  PVN secret corticotropin  
releasing hormone (CRH)  
3.  CRH induces the release of   
adrenocorticotropic hormone (ACTH)  
from pituitary gland 
4.  ACTH stimulates glucocorticoid 
secretion from adrenal cortex 
5.  Glucocorticoid acts as a negative  
regulator of  the HPA axis activity  
 
  However, hyperactivity in HPA axis regulation has been associated with MDD 
  Altered GR function and negative feedback regulation 
  Increased glucocorticoid levels 
                                                          
 
 
 
 
 
Tanapat P. study exposed pups 
rats to the odor of  a known predator and examined  
plasma corticosterone (cortisol in humans) levels.  
 
 
 
 
 
 
 
 
 
 
 
 
Authors have shown that antidepressants modulate GR function.  
Funato, H. et al. found that the application of  anti-inflammatory  
drugs along with an antidepressant, reduce translocation time of  the  
GRalpha into the nucleus, where start its function. Moreover, an  
increased in GRalpha mRNA by antidepressants has also been  
described in studies that have measured the effect of  different  
classes of  antidepressants treatments, such as Citalopram. 
 
 
 
 
 
A large literature exists demonstrating that excess pro-inflammatory cytokines contribute to the 
depression symptoms by stimulating the HPA axis activity. 
The results among several different scientific studies performed up to day about changes in the mRNA 
expression of  the different isoforms of  GR in patients with depression compared to control subjects 
show consensus on the decreases expression of  GRalpha occurred in individuals suffering depression, 
and also on the GRtotal. However, there are highly variable levels of  GRbeta mRNA expression between 
different articles in depressive patients. This shows the evident necessity of  more scientific investigations 
on the role of  GRbeta in HPA hyperactivity, inflammation and depressive symptoms. 
All these findings generate an important key question: Is it GR impairment a consequence of  depressive 
symptoms, or is it people who have GR malfunction more vulnerable to develop MDD? 
 
Glucocorticoid receptor imbalance in Major Depressive Disorder 
Stress is known to activate different neuronal circuits in the brain and induce multiple cellular changes. Researchers 
have tied inflammation as one of  the body’s natural response to stress. 
 
 
The physiological effects of environmental stress are adaptive and natural responses to situations perceived 
by the individual as a biological or physical danger, and have implications for mental and physical health. The result of  
these effects is adaptive behaviours such as “fight or flight”, activating the release of: 
  Epinephrine, Norepinephrine 
  Glucocorticoids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
The immune system initiates a cascade of  inflammatory processes to protect the body from injury or infection and 
promote healing.  
  pro-inflammatory cytokines such as Interleukin (IL1)-1, IL2, IL12, Interferon-gamma (IFNgamma) and Tumor 
Necrosis Factor-alpha (TNFalpha) 
  anti-inflammatory cytokines such as IL4 and IL10 
 
Inflammation can be damaging to the organism when it is inappropriate or chronic, and it becomes uncontrolled that 
is what happens in depressive people. For this reason, inflammation is regulated and controlled at several levels, mostly 
carried out by hormones called glucocorticoids that modulate immune responses through gene expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 NATURAL BODY RESPONSES TO STRESS 
Mood depressive disorder (MDD) is a biologically and genetically heterogeneous disorder influenced by 
environmental and psychological factors. Involves significant burden of  disease from morbidity and mortality, and is 
among the leading causes of  reduced quality of  life throughout the world.  
The aim of  this study is the literature review of  possible biological causes and consequences of  mental illness 
depression, specifically the role of  the GR mRNA expression.  
Glucocorticoids 
Epinephrine 
Norepinephrine 
  blood pressure 
  heart rate 
  blood flow to the muscles 
  glucose blood concentration 
Cytokines 
  Restore homeostasis 
Epinephrine 
Norepinephrine 
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 NEUROBIOLOGICAL BASIS OF MDD 
 
The glucocorticoid receptor is a  
nuclear receptor that binds to  
glucocorticoid in the cytoplasm to act  
as a transcription factor. GR is kept in inactive state,  
and once bind to glucocorticoid, induces a conformational  
change of  the receptor that induces dimerization and it switch  
into active state. Then, translocation along with its ligand into the  
nucleus is produced and the DNA binding domain binds to  
glucocorticoid response elements (GREs) on the DNA to  
modulate specific gene transcription.  
 
There are two isoforms of  GR: 
 
 
 
Leading to partial glucocorticoid resistance 
  Effects of  glucocorticoids on metabolic and immune functions are 
diminished 
Ref: Funato, H. et al. (2006) 
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 CONCLUDING COMMENTS 
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The ratio imbalance GRalpha/GRbeta has been found in many 
mental illnesses, especially in MDD. 
  Gralpha  acts as ligand 
activator of  transcription factor 
  Grbeta  acts as GRalpha  
Inhibitor  
Increasing evidences show the association between elevated levels of  inflammatory cytokines, GR 
impairment and MDD  
 
Genetics variations involved in the regulation of  stress 
response, HPA axis activity, glucocorticoids negative  
feedback, and glucocorticoid levels have probably  
important influence on abnormal adaptation to stress  
and the risk of  developing MDD. The heritability of   
major depression is likely to be in about 30%. Some single 
nucleotide polymorphisms may have effects on GR gene  
transcription and/or GR function. 
 
  NR3C: human gene coding for the GR.  
  FKBP5: gen codes for the FKBP5 binding protein, which 
regulates the GR sensitivity. 
Ref: Tanapat P., et al. (1998) 
Paola Maddaloni Marín 2014/15   
Protein 
